A panel of six genes (PBRM1, BAP1, SETD2, KDM5C, FOXC2, and CLIP4) was chosen for mutational frequency analysis based on the clinical relevance of significantly mutated genes across all ccRCC cohorts [12,13]. The gene discussed is FOXC2; the disease is nonpapillary renal cell carcinoma.